Join Drs. Wagner & Neeta Somaiah online Friday, October 11 for a Seminars & Tumor Board event on dedifferentiated #liposarcoma (DDLPS)! These aggressive tumors are associated with a poor prognosis; however, an emerging understanding of murine-double minute 2 (MDM2) amplification on disease pathogenesis has led to novel targeted strategies. Hear cases from the panelists’ own practice that have been designed to mimic Tumor Board discussions and decision-making and highlight the key roles of medical oncologists and other essential interprofessional team members involved in the care of DDLPS when integrating emerging targeted strategies. Register today: https://bit.ly/SARC2024L #MedEd #Oncology #sarcoma Developed in partnership with PVI, PeerView Institute for Medical Education
SARC-Sarcoma Alliance for Research through Collaboration
Research Services
Ann Arbor, MI 391 followers
Connecting individuals and organizations around the world committed to finding a cure for sarcoma.
About us
SARC is a U.S.-based 501 (c)(3) non-profit cancer research organization dedicated to the development and support of research for the prevention, treatment, and cure of sarcoma – a cancer of the bone and connective tissues of the body. SARC was founded by a small group of physicians specializing in sarcoma. Recognizing the value of pooling their intellectual and patient resources, a core group of medical and pediatric sarcoma experts at five major medical facilities formed SARC in 2003 to conduct innovative and rigorous sarcoma research to advance the care of their patients. Today, the leadership of SARC consists of respected sarcoma physicians across the country, working together to develop new strategies to improve the outcomes for sarcoma patients. The sarcoma field is small, and the need for fostered collaborations is critical. We can help improve patient outcomes and ultimately achieve a cure with your support. Find a clinical trial: https://sarctrials.org/research/sarc-clinical-trials/ Learn about our tumor board: https://sarctrials.org/education/sarc-tumor-board/ Find a sarcoma center: https://sarctrials.org/education/sarcoma-centers-worldwide/ Learn about our research funding opportunities: https://sarctrials.org/research/funding-opportunities/ Listen to our podcast: https://sarctrials.org/education/sarc-talk-podcast/ Meet our team: https://sarctrials.org/about-sarc/team/ Partner with us: https://sarctrials.org/partner-with-us/ Consider a donation: https://sarctrials.org/donate/
- Website
-
https://sarctrials.org/
External link for SARC-Sarcoma Alliance for Research through Collaboration
- Industry
- Research Services
- Company size
- 2-10 employees
- Headquarters
- Ann Arbor, MI
- Type
- Nonprofit
- Founded
- 2003
- Specialties
- Sarcoma Clinical Trials, Sarcoma Patient Education, Research Grants, and Tumor Board
Locations
-
Primary
Get directions
Ann Arbor, MI 48106, US
Employees at SARC-Sarcoma Alliance for Research through Collaboration
-
JOHN HOPPER
President| Board of Directors| Biotech| Cancer Foundations| Business Advisor| BPO| Venture Capital|Patient Activator
-
Steven Young
President & Chief Executive Officer at SARC (Sarcoma Alliance for Research Through Collaboration)
-
Carrie Bergmans
Physician Assistant at the University of Michigan Health System
-
Lisa De Young
Sarcoma Coalition | Steering Committee- Operations | Sarcoma Patient Advocacy
Updates
-
The Sarcoma Alliance is hosting a two-day educational virtual event dedicated to sarcoma patients and the people who support them. For more information and to register, please follow the QR code or visit https://lnkd.in/eRAzH-A4.
-
-
The latest SARC Talk episode highlights Dr. Angela Hong discussing international clinical trials, SARC032, and more. Take a listen: https://lnkd.in/eYhT63Ze
SARC Talk Episode 19 - Dr. Angela Hong
https://www.youtube.com/
-
The latest SARC Talk features Dr. Brian Crompton. Dr. Crompton speaks the research his laboratory teams does using proteomic and genomic methods to enhance the comprehension of cancer biology and more. To learn more about this research, visit Dr. Crompton's laboratory website https://lnkd.in/euYPnunM . Watch now on YouTube: https://lnkd.in/epMKa32r
SARC Talk Episode 18 - Dr. Brian Crompton
https://www.youtube.com/
-
SARC is honored to sponsor the SARC032 trial and extends special thanks to our partners Stand Up To Cancer, Merck, Dr. David Kirsch and many more. We are thrilled about this significant research advancement. #SarcomaAwarenessMonth
Soft-tissue sarcomas are very aggressive cancers of the muscles, fat, and connective tissues. With little progress for decades, a breakthrough is game-changing. This #SarcomaAwarenessMonth, we are highlighting a clinical trial funded by #StandUpToCancer, which showed very promising results when treating patients with this disease using immunotherapy alongside radiation and surgery. This breakthrough reduces the risk of cancer relapse by an amazing 43% – for two of the most common types of soft tissue sarcoma in adults, two years after treatment. Thank you to Merck, our Scientific Partner American Association for Cancer Research, and trial sponsor SARC-Sarcoma Alliance for Research through Collaboration for their support of this clinical trial!
-
The newest SARC Talk features two members from our Research Advocacy Council: Carolyn Dewalt and Val Stevenson. These two discuss their journey into sarcoma advocacy and their efforts in spreading sarcoma awareness. Listen now: https://lnkd.in/eW7iGB4j
SARC Talk Episode 17 - RAC: Carolyn Dewalt & Val Stevenson
https://www.youtube.com/
-
Gastrointestinal Stromal Tumors (GIST) is one of the most common forms of sarcoma. There may be as many as 4,000 new GIST patients per year in the United States. SARC, alongside sarcoma research leaders like Cogent Biosciences, Dana Farber Cancer Institute and The Life Raft Group, is committed to collaborating to advance treatment options for GIST patients. Visit the link below to learn about trends in GIST research and stay connected with SARC for an exciting announcement! https://lnkd.in/eK2S3cgN
Press Releases | Cogent Biosciences, Inc.
investors.cogentbio.com
-
The latest SARC Talk episode features the Sarcoma Sisters! Be sure to take a listen: https://lnkd.in/ezU-BAX7
SARC Talk - Episode 16 - Sarcoma Sisters
https://www.youtube.com/
-
ANNOUNCEMENT! We are pleased to announce the launch our Sarcoma Centers Registry. This serves as a resource for patients to streamline access to expert sarcoma centers worldwide. Read more here: https://lnkd.in/e5nqdq4F Visit our website here: https://lnkd.in/eutwGDpN
SARC LAUNCHES GLOBAL SARCOMA CENTERS REGISTRY SUPPORTING PATIENT AND CLINICIAN ACCESS TO PROGRAMS EXPERT IN THE DIAGNOSIS AND TREATMENT OF SARCOMA (RARE AND ULTRARARE CANCER TYPES COMPRISING 15-20% OF CHILDHOOD CANCERS AND 1% OF ADULT CANCERS)
prnewswire.com